Back

LCZ696 (sacubitril/valsartan) alleviates residual cardiac remodeling of large ventricular aneurysms after surgical ventricular reconstruction by mediating circMap4k2/LIN28A/PDK1 pathway

30 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Heart failure: new scientific insights (1) Heart Failure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Junyu Yan

Guangdong Provincial People's Hospital, Guangzhou (China)

7 More presentations in this session

Presentation thumbnail
Interleukin-22 inhibits right ventricular remodelling by a unique mechanism in a pulmonary artery constriction model.
Doctor K. Shibao (Kurume, JP)
Abstract Slides
Presentation thumbnail
Milk-derived extracellular vehicles alleviate heart failure with preserved ejection fraction by modulating gut microbiota
Miss S. Zhang (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
CD14 blockade preserves left ventricular structure and systolic function in a murine model of ST-elevation myocardial infarction.
Doctor D. Donner (Melbourne, AU)
Abstract Slides
Presentation thumbnail
The STRIPAK associated kinase MST4 is a novel mediator in heart failure pathogenesis
Mr M. Leye (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Daily Subcutaneous injections of Relaxin is a therapy for heart failure with preserved ejection fraction
Professor G. Salama (Pittsburgh, US)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: new scientific insights (1)

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
thumbnail
Congress Session
Young Investigator Award Session in Basic and Translational Sciences
thumbnail
Congress Session
Late-Breaking Basic & Translational Science

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources